# BV Financial, Inc.: financial statements, quarterly

BVFL · Nasdaq · CIK 1302387 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bvfl.md) · [Financials](/companies/bvfl/financials.md) · [Filings](/companies/bvfl/filings.md) · [Insiders](/companies/bvfl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bvfl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [2,839](/filings/0000950170-23-062612.md) | [2,562 d](/filings/0000950170-24-035306.md) | [3,041](/filings/0000950170-24-058411.md) | [2,708](/filings/0000950170-24-095817.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [1,399](/filings/0000950170-24-125992.md) | [1,011 d](/filings/0000950170-25-045947.md) | [1,026](/filings/0000950170-25-069955.md) | [1,320](/filings/0000950170-25-107717.md) | [1,442](/filings/0001193125-25-279386.md) | [895 d](/filings/0001193125-26-128285.md) | [599](/filings/0001193125-26-216089.md) | [1,076](/filings/0001193125-26-346096.md) | [1,440](/filings/0001193125-25-279386.md) | [2,252 d](/filings/0001193125-26-128285.md) | [961](/filings/0001193125-26-216089.md) | [1,269](/filings/0001193125-26-346096.md) |
| Net income | $k | [3,684](/filings/0000950170-24-125992.md) | [3,009 d](/filings/0000950170-25-045947.md) | [2,574](/filings/0000950170-25-069955.md) | [3,399](/filings/0000950170-25-107717.md) | [3,798](/filings/0001193125-25-279386.md) | [1,952 d](/filings/0001193125-26-128285.md) | [2,099](/filings/0001193125-26-216089.md) | [2,861](/filings/0001193125-26-346096.md) | [3,730](/filings/0001193125-25-279386.md) | [4,805 d](/filings/0001193125-26-128285.md) | [1,091](/filings/0001193125-26-216089.md) | [3,462](/filings/0001193125-26-346096.md) |
| Diluted EPS | $ per share | [0.35](/filings/0000950170-24-125992.md) | not reported | [0.24](/filings/0000950170-25-069955.md) | [0.32](/filings/0000950170-25-107717.md) | [0.35](/filings/0001193125-25-279386.md) | not reported | [0.21](/filings/0001193125-26-216089.md) | [0.29](/filings/0001193125-26-346096.md) | [0.41](/filings/0001193125-25-279386.md) | not reported | [0.13](/filings/0001193125-26-216089.md) | [0.42](/filings/0001193125-26-346096.md) |
| Basic EPS | $ per share | [0.35](/filings/0000950170-24-125992.md) | not reported | [0.24](/filings/0000950170-25-069955.md) | [0.32](/filings/0000950170-25-107717.md) | [0.35](/filings/0001193125-25-279386.md) | not reported | [0.21](/filings/0001193125-26-216089.md) | [0.29](/filings/0001193125-26-346096.md) | [0.41](/filings/0001193125-25-279386.md) | not reported | [0.13](/filings/0001193125-26-216089.md) | [0.43](/filings/0001193125-26-346096.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [114](/filings/0000950170-23-062612.md) | [73.7](/filings/0000950170-25-045947.md) | [78.8](/filings/0000950170-24-058411.md) | [90.6](/filings/0000950170-24-095817.md) | [94.1](/filings/0000950170-24-125992.md) | [70.5](/filings/0001193125-26-128285.md) | [70.8](/filings/0000950170-25-069955.md) | [56.3](/filings/0000950170-25-107717.md) | [63.5](/filings/0001193125-25-279386.md) | [55.7](/filings/0001193125-26-346096.md) | [74.6](/filings/0001193125-26-216089.md) | [68.9](/filings/0001193125-26-346096.md) |
| Total assets | $m | [931](/filings/0000950170-23-062612.md) | [885](/filings/0000950170-25-045947.md) | [893](/filings/0000950170-24-058411.md) | [897](/filings/0000950170-24-095817.md) | [893](/filings/0000950170-24-125992.md) | [912](/filings/0001193125-26-128285.md) | [922](/filings/0000950170-25-069955.md) | [908](/filings/0000950170-25-107717.md) | [909](/filings/0001193125-25-279386.md) | [912](/filings/0001193125-26-346096.md) | [911](/filings/0001193125-26-216089.md) | [878](/filings/0001193125-26-346096.md) |
| Total liabilities | $m | [736](/filings/0000950170-23-062612.md) | [686](/filings/0000950170-25-045947.md) | [691](/filings/0000950170-24-058411.md) | [692](/filings/0000950170-24-095817.md) | [683](/filings/0000950170-24-125992.md) | [716](/filings/0001193125-26-128285.md) | [724](/filings/0000950170-25-069955.md) | [710](/filings/0000950170-25-107717.md) | [719](/filings/0001193125-25-279386.md) | [728](/filings/0001193125-26-346096.md) | [727](/filings/0001193125-26-216089.md) | [695](/filings/0001193125-26-346096.md) |
| Long-term debt | $m | [74.7](/filings/0000950170-23-062612.md) | [37.3](/filings/0000950170-25-045947.md) | [34.8](/filings/0000950170-24-058411.md) | [34.8](/filings/0000950170-24-095817.md) | [34.8](/filings/0000950170-24-125992.md) | [49.9](/filings/0001193125-26-128285.md) | [49.9](/filings/0000950170-25-069955.md) | [35.0](/filings/0000950170-25-107717.md) | [35.0](/filings/0001193125-25-279386.md) | [35.0](/filings/0001193125-26-128285.md) | not reported | not reported |
| Shareholders' equity | $m | [195](/filings/0000950170-24-125992.md) | [199](/filings/0001193125-26-128285.md) | [202](/filings/0000950170-25-107717.md) | [205](/filings/0001193125-25-279386.md) | [210](/filings/0001193125-25-279386.md) | [195](/filings/0001193125-26-346096.md) | [198](/filings/0001193125-26-346096.md) | [198](/filings/0001193125-26-346096.md) | [190](/filings/0001193125-25-279386.md) | [184](/filings/0001193125-26-346096.md) | [184](/filings/0001193125-26-346096.md) | [183](/filings/0001193125-26-346096.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(49.3) d](/filings/0000950170-24-125992.md) | [3.5 d](/filings/0000950170-25-045947.md) | [4.6](/filings/0000950170-25-069955.md) | [1.5 d](/filings/0000950170-25-107717.md) | [6.1 d](/filings/0001193125-25-279386.md) | [3.9 d](/filings/0001193125-26-128285.md) | [4.8](/filings/0001193125-26-216089.md) | [4.4 d](/filings/0001193125-26-346096.md) | [6.4 d](/filings/0001193125-25-279386.md) | [3.4 d](/filings/0001193125-26-128285.md) | [3.7](/filings/0001193125-26-216089.md) | [4.4 d](/filings/0001193125-26-346096.md) |
| Capital expenditure | $m | [(0.0) d](/filings/0000950170-24-125992.md) | [0.0 d](/filings/0000950170-25-045947.md) | [0.4](/filings/0000950170-25-069955.md) | [0.1 d](/filings/0000950170-25-107717.md) | [0.1 d](/filings/0001193125-25-279386.md) | [0.0 d](/filings/0001193125-26-128285.md) | [0.2](/filings/0001193125-26-216089.md) | [0.1 d](/filings/0001193125-26-346096.md) | [0.0 d](/filings/0001193125-25-279386.md) | [(0.1) d](/filings/0001193125-26-128285.md) | [0.0](/filings/0001193125-26-216089.md) | [0.1 d](/filings/0001193125-26-346096.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [1.0](/filings/0001193125-26-216089.md) | [4.3 d](/filings/0001193125-26-346096.md) | [12.8 d](/filings/0001193125-25-279386.md) | [12.0 d](/filings/0001193125-26-128285.md) | [2.0](/filings/0001193125-26-216089.md) | [4.6 d](/filings/0001193125-26-346096.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0000950170-23-062612.md) | [8.0](/filings/0000950170-24-058411.md) | [8.0](/filings/0000950170-24-095817.md) | [10.6](/filings/0000950170-24-125992.md) | [10.6](/filings/0000950170-25-069955.md) | [10.7](/filings/0000950170-25-107717.md) | [10.8](/filings/0001193125-25-279386.md) | [10.0](/filings/0001193125-26-216089.md) | [9.9](/filings/0001193125-26-346096.md) | [9.1](/filings/0001193125-25-279386.md) | [8.2](/filings/0001193125-26-216089.md) | [8.3](/filings/0001193125-26-346096.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,470,604 at 2026-08-07, from the cover of the [10-Q filed 2026-08-12](/filings/0001193125-26-346096.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.